Welcome to our dedicated page for Advanced Oxygen Technologies I SEC filings (Ticker: AOXY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Advanced Oxygen Technologies I's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Advanced Oxygen Technologies I's regulatory disclosures and financial reporting.
Advanced Oxygen Technologies, Inc. reported modestly higher rental revenue and small profits for the quarter ended March 31, 2026. Revenue came entirely from a single Danish real estate lease, rising to $12,011 for the quarter and $35,516 for the nine months, with changes largely driven by lease terms and currency fluctuations.
Net income was $3,453 for the quarter and $2,657 for the nine months, reflecting low operating expenses but also higher income taxes. The balance sheet is small, with total assets of $654,955, mostly land in Denmark, and cash of only $34,626. The company had a working capital deficit of $220,447, including a $127,029 note payable due in 2027 and advances from a related party, which it partially repaid during the period.
The business remains highly concentrated: all revenue comes from one tenant and one property, and the Sharx distribution segment had no sales. Management continues to seek acquisitions and financing. The CEO, who also serves as CFO, concluded that disclosure controls and procedures were not effective, though no new control changes were implemented in the period.
Advanced Oxygen Technologies, Inc. reported very small but positive quarterly results driven entirely by rent from its Danish real estate subsidiary ANV. For the three months ended December 31, 2025, revenue was $11,724, down slightly from $13,256 a year earlier, all from lease income.
Quarterly net income was $2,649, versus $5,152 in the prior-year quarter, while the six-month period showed a small net loss of $796 compared with income of $677 a year earlier. Cash declined to $33,958 and the company reported a working capital deficit of $218,931, reflecting reliance on short-term obligations and related-party advances.
Operations remain highly concentrated: 100% of revenue comes from one tenant in Denmark, and the main asset is land valued at $634,941. Management again concluded that disclosure controls and procedures were not effective, though no legal proceedings or off-balance sheet arrangements were reported.
Advanced Oxygen Technologies (AOXY) filed its Q1 FY2026 10‑Q, reporting lease-driven revenue of $11,781, up from $10,885 on currency effects, and a net loss of $3,445 versus $4,475 a year ago. Operations are concentrated in Denmark through ANV’s land lease; Sharx recorded no commission revenue.
Cash was $45,546, total assets $681,212, liabilities $268,406, and stockholders’ equity $412,806. The company had a working capital deficit of $94,658 and generated $10,436 in operating cash flow while using $22,221 for debt repayments. Notes payable of $127,029 are classified current after extension and interest waiver through June 30, 2026. Advances from a related party were $40,953.
Management disclosed disclosure controls and procedures were not effective as of September 30, 2025. No legal proceedings or unregistered sales were reported. Revenue came 100% from international operations. Common shares outstanding were 3,292,945 as of November 7, 2025.